• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性呼吸窘迫综合征的代谢特征:新冠病毒感染所致与非新冠病毒感染所致

Metabolic signatures of acute respiratory distress syndrome: COVID versus non-COVID.

作者信息

Ji Xiangming, Ji Hong-Long

机构信息

Department of Nutrition, Georgia State University, Atlanta, Georgia, United States.

Burn and Shock Trauma Research Institute, Stritch School of Medicine, Loyola University Chicago Health Sciences Division, Maywood, Illinois, United States.

出版信息

Am J Physiol Lung Cell Mol Physiol. 2024 May 1;326(5):L596-L603. doi: 10.1152/ajplung.00266.2023. Epub 2024 Mar 12.

DOI:10.1152/ajplung.00266.2023
PMID:38469648
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11380973/
Abstract

Acute respiratory distress syndrome (ARDS) is a fatal pulmonary disorder characterized by severe hypoxia and inflammation. ARDS is commonly triggered by systemic and pulmonary infections, with bacteria and viruses. Notable pathogens include , , , coronaviruses, influenza viruses, and herpesviruses. COVID-19 ARDS represents the latest etiological phenotype of the disease. The pathogenesis of ARDS caused by bacteria and viruses exhibits variations in host immune responses and lung mesenchymal injury. We postulate that the systemic and pulmonary metabolomics profiles of ARDS induced by COVID-19 pathogens may exhibit distinctions compared with those induced by other infectious agents. This review aims to compare metabolic signatures in blood and lung specimens specifically within the context of ARDS. Both prevalent and phenotype-specific metabolomic signatures, including but not limited to glycolysis, ketone body production, lipid oxidation, and dysregulation of the kynurenine pathways, were thoroughly examined in this review. The distinctions in metabolic signatures between COVID-19 and non-COVID ARDS have the potential to reveal new biomarkers, elucidate pathogenic mechanisms, identify druggable targets, and facilitate differential diagnosis in the future.

摘要

急性呼吸窘迫综合征(ARDS)是一种以严重缺氧和炎症为特征的致命性肺部疾病。ARDS通常由全身性和肺部感染引发,涉及细菌和病毒。值得注意的病原体包括 、 、 、冠状病毒、流感病毒和疱疹病毒。新型冠状病毒肺炎相关的ARDS代表了该疾病最新的病因学表型。由细菌和病毒引起的ARDS的发病机制在宿主免疫反应和肺间充质损伤方面存在差异。我们推测,与其他感染因子诱导的ARDS相比,新型冠状病毒肺炎病原体诱导的ARDS的全身和肺部代谢组学特征可能存在差异。本综述旨在特别在ARDS的背景下比较血液和肺标本中的代谢特征。本综述全面研究了常见的和表型特异性的代谢特征,包括但不限于糖酵解、酮体生成、脂质氧化以及犬尿氨酸途径的失调。新型冠状病毒肺炎相关的ARDS和非新型冠状病毒肺炎相关的ARDS在代谢特征上的差异有可能揭示新的生物标志物、阐明致病机制、确定可成药靶点并在未来促进鉴别诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23da/11380973/53c88bcfe5a6/l-00266-2023r01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23da/11380973/53c88bcfe5a6/l-00266-2023r01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23da/11380973/53c88bcfe5a6/l-00266-2023r01.jpg

相似文献

1
Metabolic signatures of acute respiratory distress syndrome: COVID versus non-COVID.急性呼吸窘迫综合征的代谢特征:新冠病毒感染所致与非新冠病毒感染所致
Am J Physiol Lung Cell Mol Physiol. 2024 May 1;326(5):L596-L603. doi: 10.1152/ajplung.00266.2023. Epub 2024 Mar 12.
2
Metabolomic diferences between COVID-19 and H1N1 influenza induced ARDS.COVID-19 和 H1N1 流感诱发的 ARDS 患者的代谢组学差异。
Crit Care. 2021 Nov 15;25(1):390. doi: 10.1186/s13054-021-03810-3.
3
Using a targeted metabolomics approach to explore differences in ARDS associated with COVID-19 compared to ARDS caused by H1N1 influenza and bacterial pneumonia.采用靶向代谢组学方法,探索 COVID-19 相关 ARDS 与 H1N1 流感和细菌性肺炎所致 ARDS 的差异。
Crit Care. 2024 Feb 27;28(1):63. doi: 10.1186/s13054-024-04843-0.
4
Heme-induced lung injury in human precision cut lung slices: a new model for acute lung injury.血红素诱导的人精密切割肺切片肺损伤:急性肺损伤的新模型
Respir Res. 2025 Apr 2;26(1):124. doi: 10.1186/s12931-025-03191-z.
5
Spatial mapping of SARS-CoV-2 and H1N1 lung injury identifies differential transcriptional signatures.SARS-CoV-2 和 H1N1 肺部损伤的空间图谱分析确定了不同的转录特征。
Cell Rep Med. 2021 Apr 20;2(4):100242. doi: 10.1016/j.xcrm.2021.100242. Epub 2021 Mar 23.
6
Exploring the metabolic phenotypes associated with different host inflammation of acute respiratory distress syndrome (ARDS) from lung metabolomics in mice.从肺部代谢组学角度探讨不同宿主炎症急性呼吸窘迫综合征(ARDS)相关代谢表型。
Rapid Commun Mass Spectrom. 2021 Jan 30;35(2):e8971. doi: 10.1002/rcm.8971.
7
Increased Angiotensin-Converting Enzyme 2 and Loss of Alveolar Type II Cells in COVID-19-related Acute Respiratory Distress Syndrome.COVID-19 相关急性呼吸窘迫综合征中血管紧张素转换酶 2 的增加和肺泡 II 型细胞的丢失。
Am J Respir Crit Care Med. 2021 Nov 1;204(9):1024-1034. doi: 10.1164/rccm.202012-4461OC.
8
Functional pathophysiology of SARS-CoV-2-induced acute lung injury and clinical implications.新型冠状病毒肺炎所致急性肺损伤的功能病理生理学及临床意义
J Appl Physiol (1985). 2021 Mar 1;130(3):877-891. doi: 10.1152/japplphysiol.00742.2020. Epub 2021 Jan 14.
9
Pathomechanisms Underlying Hypoxemia in Two COVID-19-Associated Acute Respiratory Distress Syndrome Phenotypes: Insights From Thrombosis and Hemostasis.两种 COVID-19 相关急性呼吸窘迫综合征表型低氧血症的发病机制:血栓形成和止血的见解。
Shock. 2022 Jan 1;57(1):1-6. doi: 10.1097/SHK.0000000000001825.
10
COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.新冠病毒病是一种系统性血管血液病:对发病机制及临床方面的见解
Angiogenesis. 2021 Nov;24(4):755-788. doi: 10.1007/s10456-021-09805-6. Epub 2021 Jun 28.

引用本文的文献

1
Lipid metabolism-related genes regulate the immune microenvironment during ex vivo lung perfusion for lung transplants.脂质代谢相关基因在肺移植的体外肺灌注过程中调节免疫微环境。
J Thorac Dis. 2025 Aug 31;17(8):6045-6065. doi: 10.21037/jtd-2025-358. Epub 2025 Aug 27.
2
Plasma phenylalanine is associated with hospital mortality in acute respiratory distress syndrome: a prospective metabolic profiling cohort study.血浆苯丙氨酸与急性呼吸窘迫综合征患者的医院死亡率相关:一项前瞻性代谢谱队列研究。
Eur J Med Res. 2025 Sep 2;30(1):833. doi: 10.1186/s40001-025-03043-y.
3
Advancing omics technologies in acute respiratory distress syndrome: paving the way for personalized medicine.

本文引用的文献

1
The biomarkers' landscape of post-COVID-19 patients can suggest selective clinical interventions.新冠病毒感染后患者的生物标志物图谱可提示有选择性的临床干预措施。
Sci Rep. 2023 Dec 15;13(1):22496. doi: 10.1038/s41598-023-49601-4.
2
Oxylipin concentration shift in exhaled breath condensate (EBC) of SARS-CoV-2 infected patients.SARS-CoV-2 感染患者呼出气冷凝物(EBC)中氧化脂浓度变化。
J Breath Res. 2023 Aug 7;17(4). doi: 10.1088/1752-7163/acea3d.
3
Multi-omic comparative analysis of COVID-19 and bacterial sepsis-induced ARDS.COVID-19 和细菌性败血症引起的 ARDS 的多组学比较分析。
急性呼吸窘迫综合征中不断发展的组学技术:为个性化医疗铺平道路。
Intensive Care Med Exp. 2025 Jun 13;13(1):61. doi: 10.1186/s40635-025-00766-4.
4
Untargeted metabolomics and lipidomics in COVID-19 patient plasma reveals disease severity biomarkers.新冠病毒病患者血浆中的非靶向代谢组学和脂质组学揭示疾病严重程度生物标志物。
Metabolomics. 2024 Dec 4;21(1):3. doi: 10.1007/s11306-024-02195-y.
5
Mapping Host-Microbe Omics Interactions in Severe Community-acquired Pneumonia.绘制重症社区获得性肺炎中宿主-微生物组学相互作用图谱
Am J Respir Cell Mol Biol. 2024 Aug 13;72(1):6-9. doi: 10.1165/rcmb.2024-0346ED.
PLoS Pathog. 2022 Sep 19;18(9):e1010819. doi: 10.1371/journal.ppat.1010819. eCollection 2022 Sep.
4
Metabolic Profiling at COVID-19 Onset Shows Disease Severity and Sex-Specific Dysregulation.新冠病毒感染发病早期的代谢组学特征可反映疾病严重程度和性别特异性失调。
Front Immunol. 2022 Jun 30;13:925558. doi: 10.3389/fimmu.2022.925558. eCollection 2022.
5
Identification of bronchoalveolar and blood immune-inflammatory biomarker signature associated with poor 28-day outcome in critically ill COVID-19 patients.鉴定与危重症 COVID-19 患者 28 天预后不良相关的支气管肺泡和血液免疫炎症生物标志物特征。
Sci Rep. 2022 Jun 9;12(1):9502. doi: 10.1038/s41598-022-13179-0.
6
Metabolomic Profiling of Plasma Reveals Differential Disease Severity Markers in COVID-19 Patients.血浆代谢组学分析揭示COVID-19患者疾病严重程度的差异标志物
Front Microbiol. 2022 Apr 27;13:844283. doi: 10.3389/fmicb.2022.844283. eCollection 2022.
7
Metabolomics Diagnosis of COVID-19 from Exhaled Breath Condensate.基于呼出气冷凝物的新型冠状病毒肺炎代谢组学诊断
Metabolites. 2021 Dec 6;11(12):847. doi: 10.3390/metabo11120847.
8
Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome.对 COVID-19 患者血清进行非靶向代谢组学分析,揭示了严重程度和预后的潜在预后标志物。
Metabolomics. 2021 Dec 20;18(1):6. doi: 10.1007/s11306-021-01859-3.
9
Inactivation of SARS-CoV-2 in clinical exhaled breath condensate samples for metabolomic analysis.临床呼出冷凝物样本中 SARS-CoV-2 的灭活用于代谢组学分析。
J Breath Res. 2021 Dec 20;16(1). doi: 10.1088/1752-7163/ac3f24.
10
Plasma metabolomic and lipidomic alterations associated with COVID-19.与新型冠状病毒肺炎相关的血浆代谢组学和脂质组学改变。
Natl Sci Rev. 2020 Jul;7(7):1157-1168. doi: 10.1093/nsr/nwaa086. Epub 2020 Apr 28.